Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures
Clinical trial NCT01261325 · COMPLETED
Trial details
- NCT number
- NCT01261325
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2014-05-01
- Enrollment
- 768
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.